drugset
Drugs / transactivator of transcription
last change Jun 2016 re-read 3 minutes ago

transactivator of transcription

also known as Tat

Protein / enzyme biologic

Developed for
HIV infectious disease
Investigated by
Barbara Ensoli, MD · Italian Ministry of Foreign Affairs - General Direction for Cooperation and Development

Trials 1

today NCT01513135 · Ph 2
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01513135 Mar 2012 → May 2014 HIV infectious disease Barbara Ensoli, MD Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as transactivator of transcription “The transactivator of transcription (Tat) protein is a key human immunodeficiency virus (HIV) virulence factor required for virus replication and transmission.” PMID 27277839 ↗ Jun 2016
Known as Tat ClinicalTrials.gov intervention name — accepted as the source's own label NCT01513135 ↗
Modality Protein / enzyme biologic “a therapeutic, recombinant, biologically active HIV-1 Tat protein vaccine” NCT01513135 ↗